
SOLVENTUM CORP
SOLVNYSETrading Snapshot
- Day Range
- $281.61 β $291.71
- 52-Week Range
- $62.38 β $90.00
- Volume
- $1.66B
- Avg Volume
- $2.14B
- Shares Outstanding
- 173.2M
- Next Earnings
- Sep 28, 2026
Fundamentals Snapshot
- Annual Revenue
- $8.32B
- Last Q Revenue
- $2.21B
- P/E Ratio
- 10.1
- P/S Ratio
- 1.7x
- EPS (TTM)
- $8.19
- Dividend Yield
- β
Why Investors Own SOLV
- βHigh-growth profile β revenue up +5.5% YoY with expanding US Equity exposure.
- βHealthy economics β 45% gross margin and 21% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About SOLVENTUM CORP
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
SOLVENTUM CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift SOLV price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
SOLVENTUM CORP announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.